Zimmer Biomet Holdings (ZBH) Total Current Liabilities (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted quarterly Total Current Liabilities of $2.9 billion for Q1 2026, up 24.81% year-over-year from $2.3 billion in Q1 2025, and up 10.86% quarter-over-quarter from $2.6 billion in Q4 2025.
Zimmer Biomet Holdings (ZBH) Total Current Liabilities (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Total Current Liabilities history runs 18 years deep, the most recent figure standing at $2.9 billion for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 24.81% year-over-year to $2.9 billion; the TTM figure through Mar 2026 stood at $2.9 billion (up 24.81% YoY), while the FY2025 annual figure was $2.6 billion, up 5.42% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $2.9 billion, up from $2.6 billion in the prior quarter.
- The five-year high for Total Current Liabilities was $3.6 billion in Q2 2024, with the low at $2.1 billion in Q3 2023.
- The 5-year median for Total Current Liabilities is $2.5 billion (2022), against an average of $2.6 billion.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities jumped 72.4% in 2024, then plunged 32.72% in 2025.
- Zimmer Biomet Holdings' Total Current Liabilities stood at $2.4 billion in 2022, then rose by 21.17% to $2.9 billion in 2023, then retreated by 14.23% to $2.5 billion in 2024, then rose by 5.42% to $2.6 billion in 2025, then increased by 10.86% to $2.9 billion in 2026.
- Business Quant data shows ZBH's Total Current Liabilities at $2.9 billion in Q1 2026, $2.6 billion in Q4 2025, and $2.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 3.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.01 Bn |
| Mar 31, 2026 | 2.86 Bn |
| Dec 31, 2025 | 2.58 Bn |
| Sep 30, 2025 | 2.40 Bn |
| Jun 30, 2025 | 2.70 Bn |
| Mar 31, 2025 | 2.29 Bn |
| Dec 31, 2024 | 2.45 Bn |
| Sep 30, 2024 | 3.57 Bn |
| Jun 30, 2024 | 3.61 Bn |
| Mar 31, 2024 | 2.80 Bn |
| Dec 31, 2023 | 2.86 Bn |
| Sep 30, 2023 | 2.07 Bn |
| Jun 30, 2023 | 2.23 Bn |
| Mar 31, 2023 | 2.34 Bn |
| Dec 31, 2022 | 2.36 Bn |
| Sep 30, 2022 | 2.30 Bn |
| Jun 30, 2022 | 2.46 Bn |
| Mar 31, 2022 | 2.67 Bn |
| Dec 31, 2021 | 3.47 Bn |
| Sep 30, 2021 | 2.94 Bn |